Sclerotherapy: A study comparing polidocanol in foam and liquid form

Phlebology

Volumn 25, Issue 1, 2010, Pages 44-49

  Uncu, H ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Cosmetic results; Foam sclerotherapy; Leg telangiectasia; Sclerotherapy; Varicose veins

Indexed keywords

ANALGESIC AGENT; POLIDOCANOL;

ADULT; ANAPHYLAXIS; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DEPIGMENTATION; DIZZINESS; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; ECCHYMOSIS; EDEMA; FEMALE; FOAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROTHROMBUS; PAIN; PRIORITY JOURNAL; SCLEROTHERAPY; SKIN DISEASE; SKIN INFLAMMATION; SKIN NECROSIS; SKIN ULCER; SPIDER VEIN; TELANGIECTASIA; TELENGIECTATIC MATTING; TREATMENT OUTCOME; VESICULAR RASH; VISUAL DISORDER;

EID: 76149130709     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2009.008064     Document Type: Article

References (23)

1. Lary BG. Varicose veins and intracutaneous telengiectasia: combined treatment in 1500 cases. South Med J 1987;80:1105-10
2. Weiss RA,Weiss MA, Goldman MP. Physicianś negative perception of sclerotherapy for venous disorders: review of a 7-year experience with modern sclerotherapy. South Med J 1992 ;85:1101-6
3. Sigg K. Treatment of varicosities and accompanying complications (ambulatory treatment of phlebitis with compression bandage). Angiology 1952;3:355-79
4. Fegan WB. Continuous compression technique of injecting varicose veins. Lancet 1963;2:109-12
5. Orbach EJ. Sclerotherapy of varicose veins: utilization of an intravenous air-block. Am J Surg 1944;66:362-6
6. Monfreux A. Traitement esclerosant des trancs saphénies et leurs collatérales de gros calibre par le methode mus. Phlebologie 1997;50:351-3
7. Cabrera Garrido JR, Cabrera Garcia-Olmedo JR, Garcia-Olmedo Dominguez MA. Elargissement des limites de la sclerotherapie: noveaux produits sclérosants. Phlebologie 1997;50:181-8
8. Tessari L. Nouvelle technique d́obtention de la scleromousse. Phlebologie 2000;53:129
9. Alos J, Carreno P, Lopez JA, Estadella B, Serra-Prat M, Marinel-Io J. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 2006;31:101-7
10. Conrad P, Malouf GM, Stacey MC. The Australian polidocanol (Aethoxysklerol) study. Phlebology 1995;21:334-6
11. Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12173 sclerotherapy sessions. Dermatol Surg 2005;31:123-8
12. Green D. Sclerotherapy for the permanent eradication of varicose veins: theoretical and practical considerations. J Am Acad Dermatol 1998;38:461-75
13. Goldman MP. Polidocanol (Aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias. J Dermatol Surg Oncol 1989;15:204-9
14. Sladen J. Compression sclerotherapy: preparation, technique, complications, and results. Am J Surg 1983;146:228-32
15. Weiss RA, Weiss MA. Resolution of pain associated with varicose and telangiectatic leg veins after compression sclerotherapy. J Dermatol Surg Oncol 1990;16:333-6
16. Frullini A, Cavezzi A. Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 2002;28:11-5
17. Cavezzi A, Frullini A, Ricci S, Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 2002;17:13-8
18. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 2003;29:1170-5
19. Kern P, Ramelet AA, Wutschert R, Bounameaux H, Hayoz D. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg 2004;30:367-72
20. Rao J, Wildemore JK, Goldman MP. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Dermatol Surg 2005;31:631-5
21. Goldman MP, Kaplan RP, Duffy DM. Postsclerotherapy hyperpigmentation: a histologic evaluation. J Dermatol Surg Oncol 1987;13:547-50
22. Zimmet SE. Sclerotherapy treatment of telangiectasias and varicose veins. Tech Vasc Interv Radiol 2003;6:116-20
23. Davis LT, Duffy DM. Determination of incidence and risk factors for postsclerotherapy. Telangiectatic matting of the lower extremity: a retrospective analysis. J Dermatol Surg Oncol 1990;16:327-30